Heights Capital Management’s Revelation Biosciences Warrant REVBW Stock Holding History
Bought
Maintained
Sold
Other funds holding REVBW
TI
Heights Capital Management's REVBW Position: Q1 2022 in Review
Heights Capital Management sold out of Revelation Biosciences Warrant (REVBW) in Q1 2022, closing a stake of 294,500 shares — an estimated $200K sold.
Heights Capital Management first reported a position in REVBW in Q1 2021 and held it in 4 quarters. The position peaked at $200K in Q4 2021. 18 funds tracked by Wall St. Rank hold REVBW as of Q1 2022.
- Heights Capital Management reported no remaining Revelation Biosciences Warrant position as of Q1 2022 after selling out during the quarter.
- Heights Capital Management sold 294,500 Revelation Biosciences Warrant shares in Q1 2022, an estimated $200K.
- Heights Capital Management first reported a position in Revelation Biosciences Warrant in Q1 2021 and held it in 4 quarters.
- Heights Capital Management's Revelation Biosciences Warrant position peaked at $200K in Q4 2021.
- 18 funds tracked by Wall St. Rank held Revelation Biosciences Warrant as of Q1 2022.
Based on Heights Capital Management's 13F filing for Q1 2022, filed 16 May 2022.